hVSIG4

Nomenclature

C57BL/6Smoc-Vsig4tm1(hVSIG4)/Smoc

Cat. NO.

NM-HU-210004

Strain State

Embryo cryopreservation

Export PDF

Gene Summary

Gene Symbol
Vsig4

Model Description

The endogenous mice Vsig4 gene was replaced by human VSIG4 gene
Research Application:inmmue therapy;drug screening

Validation Data

微信截图_20211109140208.png

Fig1. Analysis of human VSIG4 expression on the peritoneal exudate macrophages by FACS. 

The homozygous KI mouse expresses human VSIG4 on the peritoneal exudate macrophages.

image.png

Fig.2 In vivo efficacy assessment of anti-hVSIG4 in HO hVSIG4 mice bearing MC38 syngeneic tumor.

Body weight were measured twice a week of hVSIG4 mice (n=4 , 3 male and 1 female). (A) Body weight. (B) Body weight change.

image.png

Fig.3 In vivo efficacy assessment of anti-hVSIG4 in HO hVSIG4 mice bearing MC38 syngeneic tumor.

Tumor volume were measured twice a week of hVSIG4 mice. MC38 (1×106) were inoculated subcutaneously into hVSIG4 mice (6-8-week-old, n=4, 3 male and 1 female). (A) Tumor volume. (B) Relative tumor volume.


You may also like

Shanghai Model Organisms Center Inc has licensed CRISPR-Cas9 technology from Broad Institute

On Dec 16, 2018, Broad Institute and Shanghai Model Organisms Center Inc (SMOC) has entered into a non-exclusive license agreement under which Broad has granted SMOC worldwide rights to commercialize a service platform for genetically modified mouse models under Broad's intellectual property.

Learn more
Workshop:Progress and Advances in Preclinical immuno-Oncology Research

SMOC’s Annual Progress and Advances in Preclinical immuno-Oncology Research: The workshop is designed as a forum for ideas and opinions exchange on how to decrease the rate of clinical failures in oncology and immuno-oncology.

Learn more